Clinical trials · Los Angeles, CA
Recurrent Astrocytoma, IDH-Mutant, Grade 4 clinical trials in Los Angeles
We’re tracking 4 recruiting recurrent astrocytoma, idh-mutant, grade 4 studies with a site in or near Los Angeles — including Phase 1 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Los Angeles
- NCT05303519RecruitingPhase 3
Safusidenib for IDH1-mutant glioma after main treatment
This Phase 3 trial tests safusidenib, a targeted medicine, to help stop or slow the return of certain brain tumors with an IDH1 mutation. It focuses on people after initial treatment (surgery and/or radiation and temozolomide), aiming to improve outcomes during maintenance therapy.
Los Angeles, CaliforniaAges 18 years+ - NCT06815029RecruitingPhase 1
Modified immune cells for recurrent brain cancer
This trial tests a new treatment using your own immune cells that are genetically modified to find and attack brain tumor cells. It is for people with a type of brain cancer that has come back after standard therapy.
Duarte, CaliforniaAges 18 years+ - NCT07544992RecruitingPhase 1
CAR T Cells for Recurrent High-Grade Brain Tumors
This trial tests genetically engineered immune cells (CAR T cells) injected directly into the brain to treat recurring or worsening high-grade gliomas. The cells are designed to recognize and attack tumor cells that have specific markers (EGFR and IL13Rα2).
Duarte, CaliforniaAges 18 years+ - NCT06860594RecruitingPhase 1
Triapine plus radiation for recurrent brain tumors
This trial tests whether adding an experimental drug called triapine to a second round of radiation therapy can help treat brain tumors that have come back after initial treatment. It may be a good option for people with recurrent glioblastoma or astrocytoma who meet safety criteria.
Duarte, CaliforniaAges 18 years+
Hear when a new Recurrent Astrocytoma, IDH-Mutant, Grade 4 trial opens near Los Angeles, CA
We’ll email you when one opens near Los Angeles, CA — at most once a week, no account needed, unsubscribe anytime.
Recurrent Astrocytoma, IDH-Mutant, Grade 4 trials in other cities
Where these studies are running near Los Angeles
Institutions with a site for the recruiting recurrent astrocytoma, idh-mutant, grade 4 studies listed above.
- City of Hope Comprehensive Cancer Center · 3 studies
- Hoag Memorial Hospital Presbyterian
- UC Irvine Health
- University of California, Irvine Medical Center / UC Irvine Health
- University of California, Los Angeles (UCLA)
What taking part in a recurrent astrocytoma, idh-mutant, grade 4 study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting recurrent astrocytoma, idh-mutant, grade 4 studies in California.
Common questions
- Are there recurrent astrocytoma, idh-mutant, grade 4 clinical trials near Los Angeles?
- Yes. We're currently tracking 4 recruiting recurrent astrocytoma, idh-mutant, grade 4 studies with a site near Los Angeles, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a recurrent astrocytoma, idh-mutant, grade 4 study near Los Angeles?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Los Angeles to take part?
- Not necessarily. These studies have a site near Los Angeles, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a recurrent astrocytoma, idh-mutant, grade 4 trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New recurrent astrocytoma, idh-mutant, grade 4 studies open near Los Angeles regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.